Eluvixtamab (AMG-330)
Revision as of 17:46, 3 February 2019 by Warner-admin (talk | contribs) (Text replacement - "Category:Chemotherapy" to "Category:Chemotherapeutic")
Mechanism of action
Bispecific T-cell engager (BiTE) antibody that engages CD33 and CD3